DBD vs ADEA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 08, 2026

DBD

48.5
AI Score
VS
DBD Wins

ADEA

40.9
AI Score

Investment Advisor Scores

DBD

49score
Recommendation
BUY

ADEA

41score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric DBD ADEA Winner
Forward P/E 12.6422 10.5374 ADEA
PEG Ratio 0 1.5095 Tie
Revenue Growth 5.2% -8.2% DBD
Earnings Growth -82.9% -75.0% ADEA
Tradestie Score 48.5/100 40.9/100 DBD
Profit Margin 2.0% 25.0% ADEA
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD DBD

Relative Price Performance (Last 90 Days)

DBD 1M: -9.4% · 3M: -20.1% ADEA 1M: -30.0% · 3M: -42.2%

Current Technical Phase

DBD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.9%), weak momentum, RSI 38

RSI (14): 38.3 · Price: $57.34

ADEA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -11.8%), weak momentum, RSI 30

RSI (14): 29.8 · Price: $16.25

Fundamentals Snapshot

Metric DBD ADEA
Market Cap — —
Forward P/E 9.3 11.9
Trailing P/E 28.5 15.8
Revenue (TTM) — —
Revenue Growth 0.1% -0.1%
Gross Margin 0.3% 1.0%
Operating Margin 0.1% 0.2%
EPS 2.11 1.03
Dividend Yield — 0.01%

Frequently Asked Questions

Based on our detailed analysis, DBD is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.